Publications
- Treatment of high-risk aggressive B-cell non-Hodgkin lymphomas with rituximab, intensive induction and high-dose consolidation: long-term analysis of the R-MegaCHOP-ESHAP-BEAM Trial2015 | First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Genotype and Haplotype Analyses of TP53 Gene in Breast Cancer Patients: Association with Risk and Clinical Outcomes2015 | First Faculty of Medicine, Third Faculty of Medicine
- Efficacy of sunitinib in patients with metastatic or unresectable renal cell carcinoma and renal insufficiency2015 | First Faculty of Medicine
- Phase I/II clinical trial of dendritic-cell based immunotherapy (DCVAC/PCa) combined with chemotherapy in patients with metastatic, castration-resistant prostate cancer2015 | Second Faculty of Medicine
- Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial2015 | Publication without faculty affiliation
- Efficacy of everolimus in second- and third-line therapy for metastatic renal cell carcinoma: A registry-based analysis2014 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Pilsen
- Clinical and laboratory prognostic factors in patients with metastatic renal cell carcinoma treated with sunitinib and sorafenib after progression on cytokines2014 | First Faculty of Medicine, Second Faculty of Medicine
- Avastin in first-line treatment of metastatic breast cancer - our experiences: case report2013 | Second Faculty of Medicine
- Mifamurtide - a new approach to adjuvant therapy of osteosarcomas2013 | Second Faculty of Medicine
- Association of superoxide dismutases and NAD(P)H quinone oxidoreductases with prognosis of patients with breast carcinomas2012 | First Faculty of Medicine, Second Faculty of Medicine
Loading network view...
